Latest Annual Report News

Merino & Co. Limited reported a significant 36% decline in revenues alongside a $2.76 million loss for the fiscal year ended June 2025, marking a stark reversal from the prior year’s modest profit.

Finexia Financial Group has restated its FY24 financials due to a material error in expense accruals and reduced the value of its Stayco investment by $4 million following an external valuation review.

AssetOwl Limited reports a modest net profit for FY2025, driven by a significant gain on debt extinguishment, while grappling with ASX suspension and ongoing going concern challenges.

EVE Health Group has reported a 19% decline in revenue and a 17% increase in net loss for the financial year ended June 2025, highlighting ongoing challenges in its health and wellness segments.

Mustera Property Group reports an 82% plunge in revenue and a net loss of $2.6 million for the year ended June 2025, marking a stark reversal from the prior year’s profit.

Firebrick Pharma reported a substantial increase in Nasodine Nasal Spray revenues in FY25, alongside a widening net loss driven by reduced R&D incentives and increased marketing investments. The company is advancing its international rollout with new licensing deals and board appointments.

Locality Planning Energy Holdings reported a modest revenue increase for FY2025 despite a significant impairment charge, as it pivots toward a disciplined, customer-focused multi-utility model.

Prestal Holdings reported a sharp 25% revenue decline and a staggering 133% increase in net loss for FY2025, yet still declared a special dividend and capital return.

Vinyl Group Ltd reported a striking 190% revenue increase for FY2025 but remains deep in the red with a $15.8 million loss. The company’s recent acquisitions and ongoing audit spotlight a pivotal moment for its future.

Skin Elements Limited reported a 13% revenue increase and a 20% reduction in net loss for FY2025, as it progresses commercial roll-out of its natural biotech products including ECO-Nurture and SuprCuvr.

Rhythm Biosciences has significantly reduced its annual loss by 44%, boosted by a 91% rise in other income, while launching a new wholly owned subsidiary, RHY GeneType Pty Ltd.

AJ Lucas Group Limited has reported a sharp decline in its financial results for FY2025, with revenue down 8.5% and a net loss soaring to $15 million. The company also recorded a significant drop in EBITDA and profit before interest and tax, signaling tough times ahead.